IQVIA Launches Agentic AI to Boost Healthcare Workflow

Agentic AI uses NVIDIA technology to strengthen the workflows for healthcare to speed up the clinical trials and pharmaceutical commercialization, bringing therapies to patients faster.

IQVIA, a leading global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries, unveils new AI agents..

The new IQVIA’s custom-built AI agents are designed using NVIDIA technology to enhance workflows and accelerate insights for healthcare.

These specialized agentic systems are designed to manage and accelerate the pharmaceutical development workflows for IQVIA’s pharmaceutical, biotech, and medical device customers worldwide.

Agentic AI Integrates NVIDIA Technology

The IQVIA AI agents use NVIDIA NIM microservices, part of the NVIDIA AI Enterprise software platform, to route any necessary actions like speech-to-text transcription, clinical coding, structured data extraction and data summarization.

Additionally, one component offered by IQVIA’s AI orchestrator agents is target identification. This AI agent builds a knowledge base from research articles and biomedical databases, using customized AI models to identify key relationships among the data and extract insights.

Further, IQVIA orchestrator agents can also provide an understanding of how a treatment will reach patients by analyzing patient records, prescriptions, and lab results in just a few days instead of weeks.

Another agent, the clinical data review agent, uses a set of automated checks and specialized agents to catch data issues early, reducing the time taken for the data review process.

Additionally, IQVIA’s AI agents use NVIDIA NIM microservices, part of the NVIDIA AI Enterprise software platform, to streamline clinical site start-up.

Stay tuned for more such updates on Digital Health News.

Stay tuned for more such updates on Digital Health News